Home / Market News / $WAT

$WAT news and market catalysts

The 22 most recent market catalysts affecting $WAT, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

22 catalysts 4 high impact 19 bullish 0 bearish Healthcare Equipment & Supplies
Nov 10, 2026 Corporate Catalyst Bullish Impact 65
FDA 510(k) Clearance for BD OneFlow Diagnostic Tests
Waters Corporation announced FDA 510(k) clearance for its BD OneFlow LST and B-CLPD T1 Tests, designed for diagnosing B-cell non-Hodgkin lymphoma. This regulatory approval is a pos…
Nov 10, 2026 Corporate Catalyst Bullish Impact 65
Waters Corporation Receives FDA 510(k) Clearance for Flow Cytometry Clinical Tests
Waters Corporation has secured FDA 510(k) clearance for its flow cytometry clinical tests, which are crucial for diagnosing leukemia and lymphoma. This approval is a significant st…
Nov 3, 2026 Corporate Catalyst Bullish Impact 85
Waters Corporation Acquires MOBILion Systems
Waters Corporation has acquired MOBILion Systems, a strategic move to integrate SLIM ion-mobility separation technology into its mass spectrometry portfolio. This acquisition is si…
Nov 3, 2026 Corporate Catalyst Bullish Impact 92
Waters Corporation Reports Third Quarter 2026 Financial Results
Waters Corporation announced impressive third-quarter 2026 results, with total revenue reaching $1.767 billion and adjusted EPS of $4.10, significantly surpassing company guidance.…
Oct 23, 2026 Corporate Catalyst Bullish Impact 55
Waters Corporation and Labcorp Announce Partnership for HPV Screening
Waters Corporation and Labcorp have announced a strategic partnership to expand cervical cancer screening access in the US. This collaboration involves Labcorp offering the FDA-app…
Oct 20, 2026 Market Technicals Neutral Impact 55
Live On CNBC, Josh Brown Hosts Segment Titled "Josh's Best Stocks In The Market: Waters"
The headline indicates that Josh Brown, a well-known financial personality, is featuring Waters Corporation (WAT) as one of his 'best stocks.' This type of endorsement on a widely …
Oct 7, 2026 Corporate Catalyst Bullish Impact 55
Barclays Maintains Overweight on Waters, Raises Price Target to $500
Barclays analyst Luke Sergott maintained an 'Overweight' rating on Waters and raised the price target from $460 to $500. This action reflects a strengthened positive outlook from a…
Oct 1, 2026 Corporate Catalyst Bullish Impact 55
Guggenheim Maintains Buy on Waters, Raises Price Target to $490
Guggenheim analyst Subbu Nambi has raised the price target for Waters (WAT) from $440 to $490 while maintaining a 'Buy' rating. This upgrade signals increased confidence from a pro…
Sep 21, 2026 Corporate Catalyst Bullish Impact 55
Goldman Sachs Maintains Buy on Waters, Raises Price Target to $515
Goldman Sachs analyst Evie Koslosky maintained a 'Buy' rating on Waters (WAT) and raised the price target from $465 to $515. This action signals increased confidence from a major i…
Sep 9, 2026 Corporate Catalyst Bullish Impact 65
UBS Upgrades Waters to Buy, Raises Price Target to $490
UBS analyst Doug Schenkel upgraded Waters (WAT) from Neutral to Buy and significantly raised its price target from $375 to $490. This upgrade indicates a more optimistic outlook fr…
Aug 27, 2026 Corporate Catalyst Neutral Impact 65
This Waters Analyst Turns Bullish; Here Are Top 3 Upgrades For Thursday
The filing reports three analyst upgrades for BWX Technologies, The Macerich Company, and Waters Corporation. For BWXT, Wells Fargo upgraded the stock from Underweight to Equal-Wei…
Aug 27, 2026 Corporate Catalyst Bullish Impact 65
Piper Sandler Upgrades Waters to Overweight, Raises Price Target to $480
Piper Sandler analyst David Westenberg upgraded Waters (WAT) from Neutral to Overweight and raised the price target from $400 to $480. This upgrade indicates a more bullish outlook…
Aug 10, 2026 Corporate Catalyst Bullish Impact 55
Citigroup Maintains Buy on Waters, Raises Price Target to $470
Citigroup analyst Joanne Wuensch has maintained a 'Buy' rating on Waters (WAT) and raised the price target from $425 to $470. This analyst upgrade indicates increased confidence in…
Aug 5, 2026 Corporate Catalyst Bullish Impact 65
TD Cowen Upgrades Waters to Buy, Raises Price Target to $475
TD Cowen analyst Dan Brennan upgraded Waters (WAT) from a 'Hold' to a 'Buy' rating and raised the price target from $408 to $475. This move indicates a more optimistic outlook from…
Aug 5, 2026 Corporate Catalyst Bullish Impact 55
RBC Capital Maintains Outperform on Waters, Raises Price Target to $475
RBC Capital's analyst Dan Leonard has maintained an 'Outperform' rating for Waters (WAT) and raised the price target from $435 to $475. This action signals a continued positive out…
Aug 5, 2026 Market Technicals Bullish Impact 55
Evercore ISI Group Maintains Outperform on Waters, Raises Price Target to $420
Evercore ISI Group analyst Vijay Kumar has maintained an 'Outperform' rating on Waters (WAT) and slightly increased the price target from $410 to $420. This action reflects a conti…
Aug 5, 2026 Corporate Catalyst Bullish Impact 55
Wells Fargo Maintains Equal-Weight on Waters, Raises Price Target to $400
Wells Fargo analyst Evan Stampler has updated their coverage on Waters (WAT), raising the price target from $370 to $400 while maintaining an 'Equal-Weight' rating. This action sig…
Aug 5, 2026 Corporate Catalyst Bullish Impact 55
Barclays Maintains Overweight on Waters, Raises Price Target to $460
This filing discloses that Barclays analyst Luke Sergott has maintained an 'Overweight' rating on Waters (WAT) and raised the price target from $425 to $460. This is a positive sig…
Aug 4, 2026 Corporate Catalyst Bullish Impact 85
Waters shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY36 guidance.
Waters' strong Q2 performance and raised FY36 guidance are a significant positive catalyst for the company, driving its stock higher. This indicates robust demand for its analytica…
Aug 4, 2026 Corporate Catalyst Neutral Impact 75
Waters Sees Q3 Adj EPS $3.95-$4.05 vs $3.99 Est; Sees Sales $1.745B-$1.762B vs $1.753B Est
Waters Corporation (WAT) has released its Q3 adjusted EPS and sales guidance. The company's EPS outlook of $3.95-$4.05 is largely in line with the $3.99 analyst consensus, and its …
Aug 4, 2026 Corporate Catalyst Bullish Impact 92
Waters Q2 Adj. EPS $3.05 Beats $3.01 Estimate, Sales $1.645B Beat $1.623B Estimate
Waters (WAT) announced its Q2 earnings, reporting adjusted EPS of $3.05, which surpassed the analyst consensus of $3.01, and sales of $1.645 billion, exceeding the $1.623 billion e…
Jul 14, 2026 Corporate Catalyst Bullish Impact 60
Goldman Sachs Maintains Buy on Waters, Raises Price Target to $425
Goldman Sachs analyst Patrick Donnelly maintained a 'Buy' rating on Waters and raised the price target from $380 to $425. This upgrade signals increased confidence from a major inv…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.